Next Article in Journal
Barbeya oleoides Leaves Extracts: In Vitro Carbohydrate Digestive Enzymes Inhibition and Phytochemical Characterization
Next Article in Special Issue
Clove Essential Oil (Syzygium aromaticum L. Myrtaceae): Extraction, Chemical Composition, Food Applications, and Essential Bioactivity for Human Health
Previous Article in Journal
Radiolabeled Compounds for Diagnosis and Treatment of Cancer
Previous Article in Special Issue
Comparison of Volatile Organic Compounds of Sideritis romana L. and Sideritis montana L. from Croatia
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Chemical Variability and In Vitro Anti-Inflammatory Activity of Leaf Essential Oil from Ivorian Isolona dewevrei (De Wild. & T. Durand) Engl. & Diels

1
UPR de Chimie Organique, Département de Mathématiques, Physique et Chimie, UFR des Sciences Biologiques, Université Péléforo Gon Coulibaly, Korhogo BP 1328, Côte d’Ivoire
2
Laboratoire de Constitution et Réaction de la Matière, UFR-SSMT, Université Félix Houphouët-Boigny, Abidjan BP 1328, Côte d’Ivoire
3
Laboratoire Sciences Pour l’Environnement, Université de Corse—CNRS, UMR 6134 SPE, Route des Sanguinaires, 20000 Ajaccio, France
*
Author to whom correspondence should be addressed.
Molecules 2021, 26(20), 6228; https://doi.org/10.3390/molecules26206228
Submission received: 15 September 2021 / Revised: 7 October 2021 / Accepted: 11 October 2021 / Published: 15 October 2021

Abstract

:
The chemical variability and the in vitro anti-inflammatory activity of the leaf essential oil from Ivorian Isolona dewevrei were investigated for the first time. Forty-seven oil samples were analyzed using a combination of CC, GC(RI), GC-MS and 13C-NMR, thus leading to the identification of 113 constituents (90.8–98.9%). As the main components varied drastically from sample to sample, the 47 oil compositions were submitted to hierarchical cluster and principal components analyses. Three distinct groups, each divided into two subgroups, were evidenced. Subgroup I−A was dominated by (Z)-β-ocimene, β-eudesmol, germacrene D and (E)-β-ocimene, while (10βH)-1β,8β-oxido-cadina-4-ene, santalenone, trans-α-bergamotene and trans-β-bergamotene were the main compounds of Subgroup I−B. The prevalent constituents of Subgroup II−A were germacrene B, (E)-β-caryophyllene, (5αH,10βMe)-6,12-oxido-elema-1,3,6,11(12)-tetraene and γ-elemene. Subgroup II−B displayed germacrene B, germacrene D and (Z)-β-ocimene as the majority compounds. Germacrene D was the most abundant constituent of Group III, followed in Subgroup III−A by (E)-β-caryophyllene, (10βH)-1β,8β-oxido-cadina-4-ene, germacrene D-8-one, and then in Subgroup III−B by (Z)-β-ocimene and (E)-β-ocimene. The observed qualitative and quantitative chemical variability was probably due to combined factors, mostly phenology and season, then harvest site to a lesser extent. The lipoxygenase inhibition by a leaf oil sample was also evaluated. The oil IC50 (0.020 ± 0.005 mg/mL) was slightly higher than the non-competitive lipoxygenase inhibitor NDGA IC50 (0.013 ± 0.003 mg/mL), suggesting a significant in vitro anti-inflammatory potential.

Graphical Abstract

1. Introduction

Isolona Engl. is a genus belonging to the Annonaceae family and comprising about 20 species, widely distributed in tropical rain forests of West and Central Africa, and Madagascar. Five species of this genus grow wild in Côte d’Ivoire: I. cooperi, I. campanulata, I. soubreana, I. deightonii and I. dewevrei [1,2].
Isolona dewevrei (De Wild. & T. Durand) Engl. & Diels (synonym: Monodora dewevrei De Wild. & T. Durand) is an evergreen shrub or a tree that can reach 15 m in height. It has narrowly obovate to obovate or elliptic to narrowly elliptic leaves that are 10–17 cm long and 4–7 cm wide, with an acuminated apex. The inflorescences appear on leafy branches and sometimes on older ones, whereas the fruits are ovoid (6–7 cm long, 4–5 cm in diameter), smooth but very finely ribbed, glabrous, green and yellow at maturity [1]. Although no ethno-pharmacological use of I. dewevrei was reported in the literature, other Isolona species (I. cooperi and I. campanulata) are traditionally used as herbal medicine in Côte d’Ivoire to treat bronchial ailments, skin diseases, hematuria and infertility, and to facilitate childbirth [1,2].
Previous studies of some solvent extracts reported several alkaloids, sterols and sesquiterpenes, as well from I. maitlandii, I. cauliflora, I. pilosa, I. campanulata, I. zenkeri and I. hexaloba, as from I. cooperi, from Côte d’Ivoire [3,4,5,6,7,8,9,10,11]. The chemical composition of the leaf, stem bark, root bark essential oils from I. cooperi and leaf essential oil from I. campanulata were also determined. The leaf and stem bark oils from I. cooperi were dominated by (Z)-β-ocimene and γ-terpinene, while the prevalent compounds of the root bark were 5-isopentenylindole and (E)-β-caryophyllene [12]. The leaf essential oil from I. campanulata was a sesquiterpene-rich oil. Its main compounds were either eudesm-5-en-11-ol, or (E)-β-caryophyllene and α-humulene [13].
In our previous works, we investigated and reported for the first time the chemical composition of the leaf, root and stem bark essential oils from I. dewevrei. The structure of germacrene D-8-one, a new natural compound, was elucidated after isolation from the stem bark essential oil. The major compounds of the root oil were cyperene and camphene, followed by 5-isopentenylindole, β-elemene and (Z)-α-bisabolene, whereas the stem bark oil was dominated by cyperene associated with β-elemene, (Z)-α-bisabolene, (E)-β-caryophyllene and α-copaene [14]. The leaf oil studies led to the isolation of seven new sesquiterpenes, characterized as 6,12-oxido-germacra-1(10),4,6,11(12)-tetraene (5αH,10βMe)-6,12-oxido-elema-1,3,6,11(12)-tetraene, germacra-1(10),4,7(11)-trien-6,12-γ-lactone, (1βH,5βH)-6,12-oxido-guaia-6,10(14),11(12)-trien-4α-ol, (10βH)-1β,8β-oxido-cadina-4-ene, (7βH)-germacrene D-8α-ol and (7βH)-germacrene D-8β-ol. NMR data of cadina-1(10),4-dien-8β-ol were also reported for the first time [15,16]. The studied leaf oil samples evidenced three chemical compositions dominated either by germacrene B, (5αH,10βMe)-6,12-oxido-elema-1,3,6,11(12)-tetraene, germacrene D, (Z)-β-ocimene, γ-elemene and (E)-β-caryophyllene, or by germacrene D, germacrene D-8-one, (10βH)-1β,8β-oxido-cadina-4-ene, (7βH)-germacrene D-8α-ol and cadina-1(10),4-dien-8β-ol, or by (10βH)-1β,8β-oxido-cadina-4-ene, (E)-β-caryophyllene, germacrene D, cadina-1(10),4-dien-8β-ol and caryophyllene oxide. Therefore, continuing our study on the chemical characterization of essential oils from Côte d’Ivoire [17,18,19,20,21], the chemical variability of the leaf essential oil of I. dewevrei was evaluated by investigating a larger number of oil samples (47). The in vitro anti-inflammatory activity of this essential oil was tested too.

2. Results and Discussion

The chemical composition of 47 leaf essential oil samples from I. dewevrei growing wild in Côte d’Ivoire was investigated in order to highlight possible variability. Oil samples were isolated by the hydrodistillation of fresh leaves collected at six sites of the Bossématié forest (Eastern Côte d’Ivoire) and two sites of the Haut-Sassandra forest (Western Côte d’Ivoire). The extraction yields calculated on a weight basis (w/w) were in the range of 0.094–0.506%. Analyses were carried out using a combination of GC(RI), GC-MS and 13C-NMR, following a computerized method developed at the University of Corsica [15,22]. Most of the constituents were identified by the three techniques, including the identification by 13C-NMR of components present at a content as low as 0.4–0.5% and compiled in our laboratory-made 13C-NMR spectral data library. However, several minor compounds remained unidentified despite the use of these complementary techniques. Hence, samples S2 (4.115 g), S14 (4.820 g), S24 (3.702 g), S44 (4.226 g) and S47 (3.910 g), which displayed qualitative and quantitative variations of the main constituents and the minor unidentified compounds, were separately submitted to a detailed analysis by column chromatography (CC). The CC fractions were then analyzed by the three above techniques. Finally, the 47 oil compositions were subjected to a statistical analysis, and the in vitro anti-inflammatory activity of the single monoterpene-rich oil sample (S44) was evaluated.

2.1. Detailed Analysis of Essential Oil Samples S2, S14, S24, S44 and S47

The leaf oil samples S2, S14, S24, S44 and S47 were representative of the whole sampling and displayed different chromatographic profiles with several unidentified minor components. They were separately fractionated by silica gel column chromatography, and seven fractions were eluted for each sample using a gradient of solvents, n-pentane/diethyl ether. Fractions F1 and F2 contained non-polar compounds, while medium polar components were in fractions F3–F6 and polar constituents in fraction F7. The CC fractions analysis by GC(RI), GC-MS and 13C-NMR led to the identification of various minor constituents along with the majority compounds of the samples
Special attention was paid to the identification of some compounds. For instance, eight sesquiterpenes previously isolated and characterized from the leaf essential oil of I. dewevrei were identified by their reported 13C-NMR data and retention indices [15,16]: (5αH,10βMe)-6,12-oxido-elema-1,3,6,11(12)-tetraene (fractions F3 from samples S14 and S47; 48.5 and 39.2%, respectively), 6,12-oxido-germacra-1(10),4,6,11(12)-tetraene (fraction F3 from sample S14; 7.2%), (1βH,5βH)-6,12-oxido-guaia-6,10(14),11(12)-trien-4α-ol (fraction F5 from sample S14; 56.4%), germacra-1(10),4,7(11)-trien-6,12-γ-lactone (fraction F6 from sample S14; 19.3%), (10βH)-1β,8β-oxido-cadina-4-ene (fraction F4 from samples S2, S24 and S44; 34.7, 18.6 and 14.7%, respectively), (7βH)-germacrene D-8α-ol (fraction F5 from sample S24; 29.4%), (7βH)-germacrene D-8β-ol (fraction F5 from sample S24; 9.8%) and cadina-1(10),4-dien-8β-ol (fraction F5 from sample S24; 39.2%). Similarly, germacrene D-8-one previously isolated from the stem bark essential oil of the same species was identified in fraction F3 from sample S24 (28.6%) [14].
Compounds bearing the elemane and germacrane skeletons and those co-eluting during the GC analysis needed special attention too. Indeed, under GC and GC-MS thermal conditions, germacrene compounds bearing the cyclodeca-1,5-diene sub-structure partially or totally rearranged to the corresponding elemanes (Cope transposition) [23,24]. This was the case for 6,12-oxido-germacra-1(10),4,6,11(12)-tetraene and (5αH,10βMe)-6,12-oxido-elema-1,3,6,11(12)-tetraene, and then germacrene B and γ-elemene. Therefore, their correct contents were obtained by a combination of GC(FID) and 13C-NMR as previously reported [15,16]. However, δ-elemene and β-elemene were really secondary metabolites produced by the plant and not rearranged products since germacrene A and germacrene C were not detected by 13C-NMR in the samples. The diastereoisomers (7βH)-germacrene D-8α-ol and (7βH)-germacrene D-8β-ol co-eluted on apolar and polar columns during the GC analysis. Thus, the 13C-NMR analysis allowed their identification, and their relative contents were assessed by a combination of GC(FID) and 13C-NMR [15,16].
The detailed analysis of essential oil samples S2, S14, S24, S44 and S47, by a combination of chromatographic and spectroscopic techniques led to the identification of a total of 99 compounds representing, respectively, 97.8, 96.4, 93.8, 98.9 and 98.1% of their whole composition (Table 1). Oil samples S2, S14, S24 and S47 were dominated by sesquiterpenes (76.0–92.5%), whereas sample S44 was monoterpene rich (71.2%). Significant variations appeared relative to the majority compounds. Indeed, the main constituents of oil sample S2 were santalenone (13.0%), trans-α-bergamotene (11.7%), trans-β-bergamotene (10.9%), (10βH)-1β,8β-oxido-cadina-4-ene (9.3%), β-bisabolene (8.7%) and α-santalene (8.5%). Sample S14 was dominated by germacrene B (20.8%), followed by (5αH,10βMe)-6,12-oxido-elema-1,3,6,11(12)-tetraene (10.3%), (Z)-β-ocimene (7.8%), germacrene D (7.5%), γ-elemene (6.9%) and (E)-β-caryophyllene (6.8%). Germacrene D (23.6%), germacrene D-8-one (8.7%), (7βH)-germacrene D-8-α-ol (7.8%), cadina-1(10),4-dien-8β-ol (7.6%) and (10βH)-1β,8β-oxido-cadina-4-ene (7.3%) were the most prevalent constituents of sample S24. Sample S44 was largely dominated by (Z)-β-ocimene (36.6%) and (E)-β-ocimene (30.5%), followed by germacrene D (13.8%), while β-eudesmol (22.5%), germacrene D (16.3%), α-eudesmol (12.4%), (E)-β-caryophyllene (12.4%) and (Z)-β-ocimene (10.2%) were the main compounds of sample S47. Obviously, the chemical compositions of the five essential oil samples displayed qualitative and quantitative variations (Table 1).

2.2. Chemical Variability of Leaf Essential Oil from I. dewevrei

The chemical variability of the leaf essential oil from I. dewevrei was evaluated throughout 47 samples collected from shrubs at different phenological stages, at six sites of the Bossématié forest (Eastern Côte d’Ivoire) and two sites of the Haut-Sassandra forest (Western Côte d’Ivoire), during the rainy and dry seasons. In total, 113 constituents accounting for 90.8–98.9% of the samples’ whole compositions were identified (Supplementary Materials, Table S1). All the samples except one (46/47) were largely dominated by sesquiterpenes (57.3–92.5%). Monoterpenes were prevalent in a single sample (71.2%), and the main components varied drastically from sample to sample: (Z)-β-ocimene (0.1–36.6%), germacrene D (0.2–34.0%), (E)-β-ocimene (0–30.5%), germacrene B (0.1–24.8%), β-eudesmol (0–22.5%), (10βH)-1β,8β-oxido-cadina-4-ene (0–13.7%), (5αH,10βMe)-6,12-oxido-elema-1,3,6,11(12)-tetraene (0–13.7%), limonene (tr–13.0%), santalenone (0–13.0%), (E)-β-caryophyllene (1.7–12.4%), α-eudesmol (0–12.4%), trans-α-bergamotene (0–11.7%), caryophyllene oxide (0–11.5%) and trans-β-bergamotene (0–10.9%). Therefore, the 47 essential oil compositions were subjected to a hierarchical cluster analysis (HCA) and principal component analysis (PCA) to highlight possible chemical variability.
The dendrogram from the HCA revealed three distinct groups within the 47 investigated oil samples: Group I (9 samples), Group II (19 samples) and Group III (19 samples), each consisting of two subgroups (Figure 1). The first principal factor of the PCA (F1: 44.31%), the second (F2: 22.52%) and the third (F3: 13.01%) accounted for 79.12% of the total variance of the chemical composition. The PCA map of the samples’ distribution relative to the principal axes F1 and F3 (57.32%) confirmed the three chemical composition groups (Figure 2). The Groups II and III were more homogenous than Group I. The mean contents (M) and the standard deviation (SD) of the majority compounds of the different subgroups are reported in Table 2.
The Subgroup I−A (four oil samples) was dominated by (Z)-β-ocimene (M = 18.0%, SD = 12.5%), β-eudesmol (M = 13.4%, SD = 9.7%), germacrene D (M = 12.6%, SD = 3.0%), (E)-β-ocimene (M = 11.4%, SD = 12.8%), (E)-β-caryophyllene (M = 8.0%, SD = 2.5%) and α-eudesmol (M = 7.6%, SD = 5.5%). The major compounds of Subgroup I−B (five oil samples) were (10βH)-1β,8β-oxido-cadina-4-ene (M = 10.9%, SD = 2.1%), santalenone (M = 9.0%, SD = 2.7%), trans-α-bergamotene (M = 7.8%, SD = 2.5%), trans-β-bergamotene (M = 7.8%, SD = 2.0%), α-santalene (M = 5.2%, SD = 1.8%) and β-bisabolene (M = 5.0%, SD = 2.6%). Santalenone, trans-α-bergamotene, trans-β-bergamotene, α-santalene and β-bisabolene, present in Subgroup I−B, were absent from Subgroup I−A and did not exceed 1.1% in Groups II and III. β-eudesmol and α-eudesmol did not exceed 0.2% in Group II and were absent from Subgroup III−A.
The Group II is characterized by its high content of germacrene B, (5αH,10βMe)-6,12-oxido-elema-1,3,6,11(12)-tetraene, γ-elemene and limonene. The main constituents of Subgroup II−A, which consisted of 13 oil samples, were germacrene B (M = 18.5%, SD = 4.1%), (E)-β-caryophyllene (M = 9.0%, SD = 1.8%), (5αH,10βMe)-6,12-oxido-elema-1,3,6,11(12)-tetraene (M = 7.8%, SD = 3.1%), γ-elemene (M = 6.3%, SD = 1.3%), (Z)-β-ocimene (M = 5.9%, SD = 2.7%), germacrene D (M = 5.7%, SD = 2.0%) and limonene (M = 4.4%, SD = 3.4%). The Subgroup II−B (six oil samples) was also dominated by germacrene B (M = 17.2%, SD = 4.1%), followed by germacrene D (M = 13.6%, SD = 5.2%), (Z)-β-ocimene (M = 13.2%, SD = 5.2%), (E)-β-caryophyllene (M = 7.5%, SD = 2.5%), (5αH,10βMe)-6,12-oxido-elema-1,3,6,11(12)-tetraene (M = 6.3%, SD = 4.4%), (E)-β-ocimene (M = 4.6%, SD = 1.6%) and γ-elemene (M = 4.2%, SD = 2.4%).
Group III differed from Groups I and II by its important proportions of germacrene D-8-one, (7βH)-germacrene D-8α-ol and cadina-1(10),4-dien-8β-ol. The Subgroup III−A (11 oil samples) displayed germacrene D (M = 24.1%, SD = 3.4%), (E)-β-caryophyllene (M = 8.2%, SD = 2.8%), (10βH)-1β,8β-oxido-cadina-4-ene (M = 6.4%, SD = 0.5%), germacrene D-8-one (M = 6.1%, SD = 2.2%), cadina-1(10),4-dien-8β-ol (M = 5.7%, SD = 1.2%), (7βH)-germacrene D-8-α-ol (M = 4.7%, SD = 2.3%) and (Z)-β-ocimene (M = 4.5%, SD = 1.6%) as the most prevalent compounds. Finally, germacrene D (M = 27.6%, SD = 4.1%), followed this time by (Z)-β-ocimene (M = 12.1%, SD = 2.0%), (E)-β-ocimene (M = 7.0%, SD = 1.6%), (E)-β-caryophyllene (M = 5.2%, SD = 2.1%) and (10βH)-1β,8β-oxido-cadina-4-ene (M = 4.0%, SD = 2.8%), were the majority components of Subgroup III−B (eight oil samples).
This study demonstrated both qualitative and quantitative variations of constituents within the detected groups and subgroups. The observed chemical variability of the leaf essential oil from I. dewevrei was probably due to several external factors, although genetic factors could not be completely excluded. As all samples were collected from shrubs at different phenological stages, at six sites of the Bossématié forest (Sites 1 to 6; Eastern Côte d’Ivoire) and two sites of the Haut-Sassandra forest (Sites 7 and 8; Western Côte d’Ivoire), during the rainy and dry seasons, the effect of phenology, season and harvest site on samples’ distribution into groups was examined (Figure 3). Regarding the phenology, samples collected from shrubs bearing flowers are all included in Group I, where they constituted the Subgroup I−A. Moreover, Group II is exclusively constituted of samples collected from shrubs bearing neither flowers nor fruits, while all the samples collected from shrubs bearing fruits are included in Group III. Therefore, the phenology appeared to be an important factor explaining the chemical variability of the leaf essential oil of the plant. From a seasonal point of view, samples collected during the dry season are more differenciated than those harvested during the rainy season. Indeed, the three barycenters of the samples collected during the dry season, corresponding to the three chemical groups, are furthest from the origin. In addition, Subgroups I−B, II−B and III−B exclusively consisted of samples collected during the rainy season, whereas samples from Subgroup I−A were harvested during the dry season. The effect of seasons on the chemical variability of I. dewevrei leaf oil could not therefore be overlooked. Although all the harvest sites are located in the same climatic zone (mesophilic sector; Celtis spp., Triplochiton scleroxylon and its variant of Nesogordonia papaverifera and Khaya ivorensis forests) with the same soil type (ferrallitic), the sites’ effect on the chemical variability was noticeable. In fact, the Subgroup I−A consisted of samples from Site 8, while those collected at Sites 3 and 4 were all included in Subgroup II−A. Samples from Site 7 are all included in Subgroup III−B, whereas those from Site 2 belonged to Group III. The harvest sites being sufficiently distant, their effect on the chemical variability could be related to possible microclimates or genetic differences. It could finally be argued that phenology, season and harvest site really impacted the chemical variability of the leaf essential oil from I. dewevrei.

2.3. Comparision to Literature Data

The chemical composition of the leaf essential oil from I. dewevrei differed considerably from that from I. cooperi and I. campanulata. Indeed, unlike leaves of I. dewevrei which produced a sesquiterpene-rich oil, the leaf oil from I. cooperi was largely dominated by monoterpenes: (Z)-β-ocimene (16.9–71.1%), γ-terpinene (0.6–26.3%), α-terpinene (0.3–12.7%), δ-3-carene (up to 8.8%), 5[(Z)-hexylidene]-5H-furan-2-one (1.2–7.8%) and massoia lactone (0.9–4.2%) [12]. Only (Z)-β-ocimene (0.1–26.7%) was a major compound of I. dewevrei samples, while γ-terpinene, α-terpinene and δ-3-carene did not exceed 1.1%. Moreover, 5[(Z)-hexylidene]-5H-furan-2-one and massoia lactone were not detected in I. dewevrei samples. The leaf oil from I. campanulata, on the other hand, was dominated by (E)-β-caryophyllene (8.2–30.5%), eudesm-5-en-11-ol (0.1–20.0%) and α-humulene (3.8–17.5%) [13]. Although (E)-β-caryophyllene (1.7–12.4%) was predominant in some I. dewevrei samples, its contents remained lower. In addition, eudesm-5-en-11-ol was completely absent from the leaf oil of I. dewevrei, while α-humulene was present in relatively small proportions (0.9–2.9%). Most of the other major constituents of I. dewevrei leaf oil were either absent or present at low contents in I. cooperi and I. campanulata leaf essential oils.

2.4. Evaluation of In Vitro Anti-Inflammatory Activity

The in vitro anti-inflammatory potential of I. dewevrei leaf essential oil (S44) was evaluated by determining its ability to inhibit lipoxygenases (LOX). Indeed, LOXs are nonheme iron-containing dioxygenases that convert linoleic, arachidonic and other polyunsaturated fatty acid into biologically active metabolites involved in the inflammatory and immune responses. Several inflammatory processes such as arthritis, bronchial asthma and cancer are associated with an important production of leukotrienes catalyzed by the LOX pathway from arachidonic acid [31,32,33,34]. The inhibition of the LOX pathway with inhibitors of LOX would prevent the production of leukotrienes and therefore could constitute a therapeutic target for the treating of human inflammation-related diseases. Thus, the search for new LOX inhibitors appears as critical because many exhibit significant in vitro anti-inflammatory activity.
The ability of I. dewevrei leaf essential oil to inhibit soybean lipoxygenase was determined as an indication of potential in vitro anti-inflammatory activity. I. dewevrei leaf essential oil exhibited an inhibition of LOX activity (Table 3). The percentage of inhibition increases with the concentration of the oil i.e., 10.3% at 0.005 mg/mL to 51.5% at 0.020 mg/mL of the essential oil. The IC50 values (concentration at which 50% of the lipoxygenase was inhibited) were determined for the I. dewevrei leaf essential oil and for the non-competitive inhibitor of lipoxygenase, the nordihydroguaiaretic acid (NDGA) (Table 3), usually used as a reference in in vitro anti-inflammatory assays [32,33,34]. Data showed that the IC50 value of I. dewevrei leaf essential oil (0.020 ± 0.005 mg/mL) is slightly higher than the IC50 value of NDGA (0.013 ± 0.003 mg/mL). The low ratio between the two values of IC50 (I. dewevrei leaf essential oil vs. NDGA) makes it possible to consider this essential oil as a high inhibitor of the LOX activity, suggesting an in vitro anti-inflammatory potential [35].

3. Material and Methods

3.1. Plant Material

The fresh leaves’ samples were collected on individual I. dewevrei shrubs at different phenological stages, at six sufficiently distant sites (Sites 1 to 6) of the Bossématié forest, Region of Abengourou, Eastern Côte d’Ivoire, and at two sites (Sites 7 and 8) of the Haut-Sassandra forest, Western Côte d’Ivoire. Geographical coordinates: Site 1 (6°31′34.7″ N and 3°28′15.0″ W), Site 2 (6°29′26.0″ N and 3°29′11.7″ W), Site 3 (6°27′44.9″ N and 3°32′25.5″ W), Site 4 (6°25′44.5″ N and 3°32′40.7″ W), Site 5 (6°26′07.2″ N and 3°28′27.2″ W), Site 6 (6°23′43.4″ N and 3°25′59.4″ W), Site 7 (6°53′40.2″ N and 6°55′36.3″ W) and Site 8 (6°54′52.7″ N and 6°57′21.1″ W). The harvest took place on one hand during the dry season (March 2016, January 2017 and February 2021) and during the rainy season on the other hand (April 2016, August 2016 and July 2020) (Supplementary Materials, Table S2). Plant material was authenticated by botanists from the Centre Suisse de Recherches Scientifiques (CSRS) and Centre National de Floristique (CNF) Abidjan, Côte d’Ivoire. A voucher specimen was deposited at the herbarium of CNF, Abidjan, with the reference LAA 12874.

3.2. Essential Oil Isolation and Fractionation

The essential oil samples were obtained by the hydrodistillation of fresh leaves for 3 h each, using a Clevenger-type apparatus. Yields were calculated from fresh material (w/w). Plant material and essential oil extraction data are reported in Table S2 (Supplementary material). The leaf essential oil samples S2 (4.115 g), S14 (4.820 g), S24 (3.702 g), S44 (4.226 g) and S47 (3.910 g) were separately chromatographed on a column with silica gel (Acros Organics, Waltham, MA, USA, 60–200 μm, 120 g each, except S14, 150 g), using a gradient of solvents, distilled n-pentane (VWR Chemicals, Radnor, PA, USA, 99%)/diethyl ether (VWR Chemicals, 100.0%) of increasing polarity (P/DE, 100/0 to 0/100). Seven fractions were eluted for each oil sample: F1 and F2 (eluted with n-pentane) contained hydrocarbons; F3–F6 (eluted with P/DE mixtures) contained medium polar compounds; F7 (eluted with diethyl ether) contained polar compounds. The respective weights of the fractions from the different samples are reported in the Table 4.

3.3. Gas Chromatography

Analyses were performed on a Clarus 500 PerkinElmer Chromatograph (PerkinElmer, Courtaboeuf, France), equipped with a flame ionization detector (FID) and two fused-silica capillary columns (50 m × 0.22 mm, film thickness 0.25 µm), BP-1 (polydimethylsiloxane) and BP-20 (polyethylene glycol). The oven temperature was programmed from 60 °C to 220 °C at 2 °C/min and then held isothermal at 220 °C for 20 min; injector temperature: 250 °C; detector temperature: 250 °C; carrier gas: hydrogen (0.8 mL/min); split: 1/60; injected volume: 0.5 µL. Retention indices (RI) were determined relative to the retention times of a series of n-alkanes (C8–C29) with a linear interpolation (« Target Compounds » software from PerkinElmer). The relative response factor (RFF) of each compound was calculated according to the International Organization of the Flavor Industry (IOFI)-recommended practice for the use of predicted relative response factors for the rapid quantification of volatile flavoring compounds by GC(FID) [36]. Methyl octanoate was used as an internal reference, and the relative proportion of each constituent (expressed in g/100 g) was calculated using the weight of the essential oil and reference, peak area and relative response factors (RRF).

3.4. Gas Chromatography—Mass Spectrometry in Electron Impact Mode

The essential oil samples and all fractions of chromatography were analyzed with a Clarus SQ8S PerkinElmer TurboMass detector (quadrupole), directly coupled with a Clarus 580 PerkinElmer Autosystem XL (PerkinElmer, Courtaboeuf, France), equipped with a Rtx-1 (polydimethylsiloxane) fused-silica capillary column (60 m × 0.22 mm i.d., film thickness 0.25 µm). The oven temperature was programmed from 60 to 230 °C at 2°/min and then held isothermal for 45 min; injector temperature, 250 °C; ion-source temperature, 250 °C; carrier gas, He (1 mL/min); split ratio, 1:80; injection volume, 0.2 µL; ionization energy, 70 eV. The electron ionization (EI) mass spectra were acquired over the mass range 35–350 Da.

3.5. Nuclear Magnetic Resonance

All 13C-NMR spectra were recorded on a Bruker AVANCE 400 Fourier transform spectrometer (Bruker, Wissembourg, France) operating at 100.623 MHz for 13C, equipped with a 5 mm probe, in CDCl3, with all shifts referred to via an internal TMS. The following parameters were used: pulse width = 4 µs (flip angle 45°); relaxation delay D1 = 0.1 s, acquisition time = 2.7 s for a 128 K data table with a spectral width of 25,000 Hz (250 ppm); CPD mode decoupling; digital resolution = 0.183 Hz/pt. The number of accumulated scans was 3000 for each sample or fraction (40 mg, when available, in 0.5 mL of CDCl3).

3.6. Identification of Individual Components

Identification of the individual components was carried out: (i) by a comparison of their GC retention indices on apolar and polar columns, with those of reference compounds [25,37]; (ii) by computer matching against commercial mass spectral libraries [37,38,39]; (iii) by a comparison of the signals in the 13C-NMR spectra of the samples and fractions with those of reference spectra compiled in the laboratory spectral library, with the help of a laboratory-made software [15,22]. This method allowed for the identification of individual components of the essential oil at contents as low as 0.4–0.5%.

3.7. Statistical Analysis

The chemical compositions of 47 leaf essential oil samples from I. dewevrei were submitted to a hierarchical cluster analysis (HCA) and principal component analysis (PCA) using XLSTAT software (Addinsoft, Paris, France) [40]. Only constituents in a concentration higher than 1.0% were used as variables for the PCA analysis. The aptitude of the complete correlation matrix was checked by the Kaiser–Meyer–Olkin criterion. The HCA and dendrogram were made with dissimilarity matrices calculated in Euclidean distance, and the average link was the aggregation method systematically chosen.

3.8. In Vitro Anti-Inflammatory Capacity of Isolona dewevrei Leaf Essential Oil

The in vitro anti-inflammatory capacity of I. dewevrei leaf essential oil was evaluated by an in vitro lipoxygenase inhibition assay [41,42,43]. The in vitro analysis for lipoxygenase inhibitory activity was performed using Lipoxidase type I-B (Lipoxygenase, LOX, EC 1.13.11.12) from Glycine max (soybean) purchased from Sigma-Aldrich Chimie (Saint-Quentin-Fallavier, France). It was determined by the kinetic mode of the spectrophotometric determination method, which was performed by recording the rate of change in absorbance at 234 nm. Indeed, the increase in absorbance at 234 nm was due to the formation of 13-hydroperoxides of linoleic acid (substrate used for LOX inhibition activity assay) [41,42,43].
A stock solution of LOX was prepared by dissolving around 5.7 units/mL of LOX in PBS (Phosphate Buffer Solution; 1 unit corresponding to 1 µmol of hydroperoxide formed per min). Four concentrations of I. dewevrei leaf essential oil sample (S44) in dimethylsulfoxide (DMSO) were tested as the inhibitor solution for the LOX inhibition activity assay: 0.005, 0.010, 0.015 and 0.020 mg/mL.
The LOX inhibition assays were performed by mixing 10 µL of LOX solution with 10 µL of inhibitor solution in 970 µL of boric acid buffer (50 mM; pH 9.0) and incubating them briefly at room temperature. The reaction started by the addition of 10 µL of substrate solution (Linoleic acid, 25 mM), and the velocity was recorded for 30 s at 234 nm. One assay was measured in the absence of the inhibitor solution, and one assay was measured with DMSO mixed with distilled water (99.85% of DMSO in distilled water) which made it possible to eliminate the inhibition effect of DMSO. No inhibitor effect of DMSO on the LOX activity was detected, and the LOX activity measured without inhibitor solution was considered as a control (100% enzymatic reaction). All assays were performed in triplicate. The percentage of lipoxygenase inhibition was calculated according to the equation:
Inhibition % = (V0control − V0sample) × 100/V0control
V0control is the activity of LOX in the absence of the inhibitor solution, and V0sample is the activity of LOX in the presence of the inhibitor solution [43]. The IC50 was calculated by the concentration of I. dewevrei leaf essential oil in DMSO inhibiting 50% of LOX activity.

4. Conclusions

The chemical variability of the leaf essential oil from I. dewevrei growing wild in Côte d’Ivoire was investigated through 47 oil samples. A combination of chromatographic (CC, GC(RI)) and spectroscopic (GC/MS, 13C-NMR) techniques was used to determine the samples’ chemical compositions. One hundred and thirteen constituents accounting for 90.8–98.9% of the whole sample compositions were identified, and the main components varied drastically from sample to sample. Therefore, the 47 oil compositions were submitted to hierarchical cluster and principal components analyses, which evidenced three distinct chemical groups, each dividing into two subgroups. The Subgroup I−A was dominated by (Z)-β-ocimene, β-eudesmol, germacrene D and (E)-β-ocimene, while (10βH)-1β,8β-oxido-cadina-4-ene, santalenone, trans-α-bergamotene and trans-β-bergamotene were the main compounds of Subgroup I−B. The prevalent constituents of Subgroup II−A were germacrene B, (E)-β-caryophyllene, (5αH,10βMe)-6,12-oxido-elema-1,3,6,11(12)-tetraene and γ-elemene. The Subgroup II−B displayed germacrene B, germacrene D and (Z)-β-ocimene as the majority compounds. Germacrene D was the most abundant constituent of Group III, followed in Subgroup III−A by (E)-β-caryophyllene, (10βH)-1β,8β-oxido-cadina-4-ene, germacrene D-8-one, and then in Subgroup III−B by (Z)-β-ocimene and (E)-β-ocimene. Compounds bearing the eudesmane skeleton characterized Subgroup I−A and also Subgroup III−B to a lesser extent. Likewise, santalane, bergamotane and bisabolane skeletons were markers of Subgroup I−B, while the elemane skeleton was specific to Group II. Group III markers were oxygenated germacrane and cadinane compounds. Although genetic factors could not be completely excluded, the observed qualitative and quantitative chemical variability of the leaf essential oil from I. dewevrei could be related to mostly phenology and season, then harvest site to a lesser extent. A leaf oil sample (S44) was tested for its lipoxygenase inhibition ability. The oil IC50 value (0.020 ± 0.005 mg/mL) was slightly higher than the non-competitive lipoxygenase inhibitor NDGA IC50 value (0.013 ± 0.003 mg/mL). Therefore, this leaf essential oil exhibited significant in vitro anti-inflammatory potential.

Supplementary Materials

The following are available online, Table S1 (Chemical composition of the 47 leaf essential oil samples from Isolona dewevrei) and Table S2 (Plant material, essential oil extraction and climate data).

Author Contributions

Conceptualization, D.A.K., J.B.B. and F.T.; methodology, D.A.K., J.B.B. and F.T.; software, D.A.K. and M.P.; validation, J.B.B. and F.T.; formal analysis, D.A.K.; data analysis, D.A.K., A.C.L.K. and D.B.; essential oil investigation, D.A.K., A.C.L.K. and D.B.; in vitro anti-inflammatory activity investigation, V.B.; writing—original draft preparation, D.A.K., J.B.B. and F.T.; writing—review and editing, D.A.K., J.B.B. and F.T.; visualization, D.A.K. and M.P.; supervision, J.B.B. and F.T. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in Supplementary Materials.

Acknowledgments

The authors gratefully acknowledge the University of Corsica for providing a post-doctoral grant to D. A. Kambiré. We acknowledge J. Assi and H. Téré for their valuable help in the plant identification, and Marc Gibernau for the statistical data analysis.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the essential oils are available from the authors.

References

  1. Couvreur, T.L.P. Revealing the Secrets of African Annonaceae: Systematics, Evolution and Biogeography of the Syncarpous Genera Isolona and Monodora. Ph.D. Thesis, Wageningen University, Wageningen, The Netherlands, 2008; p. 294. [Google Scholar]
  2. Aké, A.L. Flore de Côte D’ivoire: Étude Descriptive et Biogéographique avec Quelques Notes Ethno-Botaniques. Ph.D. Thesis, Université d’Abidjan, Abidjan, Côte d’Ivoire, 1984; p. 1206. [Google Scholar]
  3. Achenbach, H.; Löwell, M. Constituents of Isolona maitlandii. Phytochemistry 1995, 40, 967–973. [Google Scholar] [CrossRef]
  4. Makangara, J.J.; Henry, L.; Jonker, S.A.; Nkunya, M.H.H. The caulindoles: Dimeric prenylindoles from Isolona cauliflora. Phytochemistry 2004, 65, 227–232. [Google Scholar] [CrossRef] [PubMed]
  5. Nkunya, M.H.H.; Makangara, J.J.; Jonker, S.A. Prenylindoles from Tanzanian Monodora and Isolona species. Nat. Prod. Res. 2004, 18, 253–258. [Google Scholar] [CrossRef]
  6. Hocquemiller, R.; Cabalion, P.; Bouquet, A.; Cavé, A.; Janot, M.-M. L’isopiline, nouvel alcaloïde aporphinique isolé de l’Isolona pilosa Diels, Annonacées. C. R. Acad. Sci. Paris Sér. C 1977, 285, 447–450. [Google Scholar]
  7. Hocquemiller, R.; Cabalion, P.; Bruneton, J.; Cavé, A. Alcaloïdes des Annonacées XXIII. Alcaloïdes des écorces d’Isolona campanulata Engler et Diels. Plantes Méd. Phytothér. 1978, 12, 230–234. [Google Scholar]
  8. Hocquemiller, R.; Cabalion, P.; Fournet, A.; Cavé, A. Alcaloïdes des Annonacées XLIX. Alcaloïdes d’Isolona hexaloba, I. zenkeri et I. pilosa. Planta Med. 1984, 50, 23–25. [Google Scholar] [CrossRef] [PubMed]
  9. Leboeuf, M.; Cavé, A.; Bhaumik, P.K.; Mukherjee, B.; Mukherjee, R. The phytochemistry of the Annonaceae. Phytochemistry 1982, 21, 2783–2813. [Google Scholar] [CrossRef]
  10. Okpekon, A.T. Étude Chimique et Biologique de Plantes Ivoiriennes Utilisées en Médecine Traditionnelle en tant Qu’antiparasitaires: Afromomum sceptrum K. Schum. (Zingiberaceae), Bridelia ferruginea Benth. (Euphorbiaceae), Isolona cooperi Hutch. & Dalz. et Uvaria afzelii Sc. Elliot (Annonaceae). Ph.D. Thesis, Université Paris-Sud, France–Université de Cocody-Abidjan, Côte d’Ivoire, Paris, France, 2006; p. 283. [Google Scholar]
  11. Kabran, A.F. Étude Phytochimique de Plantes Ivoiriennes à Activité Antiparasitaire. Ph.D. Thesis, Université Paris-Sud, France–Université de Cocody-Abidjan, Côte d’Ivoire, Paris, France, 2013; p. 290. [Google Scholar]
  12. Boti, J.B.; Koukoua, G.; N’Guessan, Y.T.; Muselli, A.; Bernardini, A.F.; Casanova, J. Composition of the leaf, stem bark and root bark oils of Isolona cooperi investigated by GC (retention index), GC-MS and 13C-NMR spectroscopy. Phytochem. Anal. 2005, 16, 357–363. [Google Scholar] [CrossRef] [PubMed]
  13. Boti, J.B.; Yao, A.P.; Koukoua, G.; N’Guessan, Y.T.; Casanova, J. Components and chemical variability of Isolona campanulata Engler & Diels leaf oil. Flavour Fragr. J. 2006, 21, 166–170. [Google Scholar] [CrossRef]
  14. Kambiré, D.A.; Boti, J.B.; Ouattara, Z.A.; Yapi, A.T.; Nelly, B.; Bighelli, A.; Tomi, F. Chemical composition of root and stem bark essential oils from Ivorian Isolona dewevrei: Structural elucidation of a new natural germacrone. Nat. Prod. Res. 2021, 1–7. [Google Scholar] [CrossRef] [PubMed]
  15. Kambiré, D.A.; Boti, J.B.; Ouattara, Z.A.; Yapi, A.T.; Bighelli, A.; Tomi, F.; Casanova, J. Leaf essential oil from Ivoirian Isolona dewevrei (Annonaceae): Chemical composition and structure elucidation of four new natural sesquiterpenes. Flavour Fragr. J. 2021, 36, 22–33. [Google Scholar] [CrossRef]
  16. Kambiré, D.A.; Boti, J.B.; Yapi, T.A.; Ouattara, Z.A.; Bighelli, A.; Casanova, J.; Tomi, F. New Natural Oxygenated Sesquiterpenes and Chemical Composition of Leaf Essential Oil from Ivoirian Isolona dewevrei (De Wild. & T. Durand) Engl. & Diels. Molecules 2020, 25, 5613. [Google Scholar] [CrossRef]
  17. Nea, F.; Kambiré, D.A.; Genva, M.; Tanoh, E.A.; Wognin, E.L.; Martin, H.; Brostaux, Y.; Tomi, F.; Lognay, G.C.; Tonzibo, Z.F.; et al. Composition, Seasonal Variation, and Biological Activities of Lantana camara Essential Oils from Côte d’Ivoire. Molecules 2020, 25, 2400. [Google Scholar] [CrossRef] [PubMed]
  18. Kambiré, D.A.; Boti, J.B.; Yapi, A.T.; Ouattara, Z.A.; Paoli, M.; Bighelli, A.; Tomi, F.; Casanova, J. Composition and intraspecific chemical variability of leaf essential oil of Laggera pterodonta (DC.) Sch. Bip. ex Oliv. from Côte d’Ivoire. Chem. Biodivers. 2020, 17, e1900504. [Google Scholar] [CrossRef] [Green Version]
  19. Kambiré, D.A.; Yapi, A.T.; Boti, J.B.; Ouattara, Z.A.; Tonzibo, Z.F.; Filippi, J.J.; Bighelli, A.; Tomi, F. Two new eudesman-4α-ol epoxides from the stem essential oil of Laggera pterodonta from Côte d’Ivoire. Nat. Prod. Res. 2020, 34, 2765–2771. [Google Scholar] [CrossRef] [PubMed]
  20. Kambiré, D.A.; Boti, J.B.; Filippi, J.J.; Tonzibo, Z.F.; Tomi, F. Characterization of a new epoxy-hydroxycarvotanacetone derivative from the leaf essential oil of Laggera pterodonta from Côte d’Ivoire. Nat. Prod. Res. 2019, 33, 2109–2112. [Google Scholar] [CrossRef] [PubMed]
  21. Kambiré, D.A.; Yapi, A.T.; Boti, J.B.; Garcia, G.; Tomi, P.; Bighelli, A.; Tomi, F. Chemical composition of leaf essential oil of Piper umbellatum and aerial part essential oil of Piper guineense from Côte d’Ivoire. Nat. Prod. Commun. 2019, 14, 1–8. [Google Scholar] [CrossRef] [Green Version]
  22. Tomi, F.; Bradesi, P.; Bighelli, A.; Casanova, J. Computer-aided identification of individual components of essential oils using carbon-13 NMR spectroscopy. J. Magn. Reson. Anal. 1995, 1, 25–34. [Google Scholar]
  23. Baldovini, N.; Tomi, F.; Casanova, J. Identification and quantitative determination of furanodiene, a heat-sensitive compound, in essential oil by 13C-NMR. Phytochem. Anal. 2001, 12, 58–63. [Google Scholar] [CrossRef]
  24. Ouattara, Z.A.; Boti, J.B.; Ahibo, A.C.; Casanova, J.; Tomi, F.; Bighelli, A. Analysis of Cleistopholis patens leaf and trunk bark oils using combined GC-Flame Ionisation Detection, GC-Retention Index, GC-MS and 13C-NMR. Phytochem. Anal. 2013, 24, 574–580. [Google Scholar] [CrossRef] [PubMed]
  25. Terpenoids Library Website. Available online: https://massfinder.com/wiki/Terpenoids_Library_List (accessed on 6 October 2021).
  26. Baharum, S.N.; Bunawan, H.; Ghani, M.A.; Mustafa, W.A.W.; Noor, N.M. Analysis of the chemical composition of the essential oil of Polygonum minus Huds. using two-dimensional gas chromatography—Time of flight mass spectrometry (GC-TOF-MS). Molecules 2010, 15, 7006–7015. [Google Scholar] [CrossRef] [Green Version]
  27. Cavalli, J.-F.; Tomi, F.; Bernadini, A.-F.; Casanova, J. Composition and chemical variability of the bark oil of Cedrelopsis grevei H. Baillon from Madagascar. Flavour Fragr. J. 2003, 18, 532–538. [Google Scholar] [CrossRef]
  28. Edris, A.E.; Chizzola, R.; Franz, C. Isolation and characterization of the volatile aroma compounds from the concrete headspace and the absolute of Jasminum sambac (L.) Ait. (Oleaceae) flowers grown in Egypt. Eur. Food Res. Technol. 2008, 226, 621–626. [Google Scholar] [CrossRef]
  29. Weyerstahl, P.; Marschall, H.; Wahlburg, H.-C.; Christiansen, C.; Rustaiyan, A.; Mirdjalili, F. Constituents of the essential oil of Pulicaria gnaphalodes (Vent.) Boiss. from Iran. Flavour Fragr. J. 1999, 14, 121–130. [Google Scholar] [CrossRef]
  30. Paolini, J.; Tomi, P.; Bernardini, A.-F.; Bradesi, P.; Casanova, J.; Kaloustian, J. Detailed analysis of the essential oil from Cistus albidus L. by combination of GC/RI, GC/MS and 13C-NMR spectroscopy. N. Z. J. Agric. Res. 2008, 22, 1270–1278. [Google Scholar] [CrossRef] [PubMed]
  31. Carrasco, A.; Ortiz-Ruiz, V.; Martinez-Gutierrez, R.; Tomas, V.; Tudela, J. Lavandula stoechas essential oil from Spain: Aromatic profile determined by gas chromatography-mass spectrometry, antioxidant and lipoxygenase inhibitory bioactivities. Ind. Crops Prod. 2015, 73, 16–27. [Google Scholar] [CrossRef]
  32. Cutillas, A.-B.; Carrasco, A.; Martinez-Gutierrez, R.; Tomas, V.; Tudela, J. Thyme essential oils from Spain: Aromatic profile ascertained by GC-MS and their antioxidant, anti-lipoxygenase and antimicrobial activities. J. Food. Drug Anal. 2018, 26, 529–544. [Google Scholar] [CrossRef] [Green Version]
  33. Whitman, S.; Gezginci, M.; Timmermann, B.N.; Holman, T.R. Structure-activity relationship studies of nordihydroguaiaretic acid inhibitors toward soybean, 12-human, and 15-human lipoxygenase. J. Med. Chem. 2002, 45, 2659–2661. [Google Scholar] [CrossRef] [PubMed]
  34. Jazet Dongmo, P.M.; Kuate, J.; Ngouana, V.; Damesse, F.; Tchinda Sonwa, E.; Amvam Zollo, P.H.; Menut, C. Comparaison des propriétés anti-radicalaires et anti-inflammatoires des huiles essentielles de Citrus reticulata var. madagascar et Citrus sinensis var. casagrande du Cameroun. Fruits 2008, 63, 201–208. [Google Scholar]
  35. Kamatou, G.P.P.; Viljoen, A.M.; Gono-Bwalya, A.B.; van Zyl, R.L.; van Vuuren, S.F.; Lourens, A.C.U.; Başer, K.H.C.; Demirci, B.; Lindsey, K.L.; van Staden, J.; et al. The in vitro pharmacological activities and a chemical investigation of three South African Salvia species. J. Ethnopharmacol. 2005, 102, 382–390. [Google Scholar] [CrossRef]
  36. Cachet, T.; Brevard, H.; Chaintreau, A.; Demyttenaere, J.; French, L.; Gassenmeier, K.; Joulain, D.; Koenig, T.; Leijs, H.; Liddle, P.; et al. IOFI recommended practice for the use of predicted relative-response factors for the rapid quantification of volatile flavouring compounds by GC-FID. Flavour Fragr. J. 2016, 31, 191–194. [Google Scholar] [CrossRef] [Green Version]
  37. König, W.A.; Hochmuth, D.H.; Joulain, D. Terpenoids and Related Constituents of Essential Oils. Library of MassFinder 2.1; Institute of Organic Chemistry: Hamburg, Germany, 2001. [Google Scholar]
  38. National Institute of Standards and Technology. PC Version of the Mass Spectral Library; Norwalk: Connecticut, CT, USA, 2014. [Google Scholar]
  39. Adams, R.P. Identification of Essential Oils Components by Gas Chromatography/Mass Spectroscopy, 4th ed.; Allured: Carol Stream, IL, USA, 2001; p. 455. [Google Scholar]
  40. Legendre, P.; Legendre, L. Numerical Ecology, 2nd ed.; Elsevier Science: Amsterdam, The Netherlands, 1998; p. 853. [Google Scholar]
  41. Eshwarappa, R.S.B.; Ramachandra, Y.L.; Subaramaihha, S.R.; Subbaiah, S.G.P.; Austin, R.S.; Dhananjaya, B.L. Anti-Lipoxygenase activity of leaf gall extracts of Terminalia chebula (Gaertn.) Retz. (Combretaceae). Pharmacogn. Res. 2016, 8, 78–82. [Google Scholar] [CrossRef] [Green Version]
  42. Srivastava, P.; Vyas, V.K.; Variya, B.; Patel, P.; Qureshi, G.; Ghate, M. Synthesis, anti-inflammatory, analgesic, 5-lipoxygenase (5-LOX) inhibition activities, and molecular docking study of 7-substituted coumarin derivatives. Bioorg. Chem. 2016, 67, 130–138. [Google Scholar] [CrossRef] [PubMed]
  43. Bayala, B.; Bassole, I.H.; Gnoula, C.; Nebie, R.; Yonli, A.; Morel, L.; Figueredo, G.; Nikiema, J.-B.; Lobaccaro, J.-M.; Simpore, J. Chemical composition, antioxidant, anti-Inflammatory and anti-proliferative activities of essential oils of plants from Burkina Faso. PLoS ONE 2014, 9, e92122. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Dendrogram of hierarchical cluster analysis (HCA) of the 47 leaf oil samples from I. dewevrei.
Figure 1. Dendrogram of hierarchical cluster analysis (HCA) of the 47 leaf oil samples from I. dewevrei.
Molecules 26 06228 g001
Figure 2. Principal component analysis (PCA) of the 47 leaf oil samples from I. dewevrei.
Figure 2. Principal component analysis (PCA) of the 47 leaf oil samples from I. dewevrei.
Molecules 26 06228 g002
Figure 3. Effect of phenology, season and harvest site on the 47 oil samples’ distribution into groups.
Figure 3. Effect of phenology, season and harvest site on the 47 oil samples’ distribution into groups.
Molecules 26 06228 g003
Table 1. Chemical composition of five leaf essential oil samples from Isolona dewevrei.
Table 1. Chemical composition of five leaf essential oil samples from Isolona dewevrei.
Compounds aRIl bRIaRIpRRFS2 (%)S14 (%)S24 (%)S44 (%)S47 (%)Identification
1α-Thujene93292310160.7650.20.5tr0.10.2RI, MS, 13C-NMR
2α-Pinene93693110130.7650.10.40.1tr0.1RI, MS, 13C-NMR
3Sabinene97396511200.7650.61.80.10.21.0RI, MS, 13C-NMR
4β-Pinene97897011090.765tr0.40.1--RI, MS, 13C-NMR
5Myrcene98798111580.7650.20.60.30.90.3RI, MS, 13C-NMR
6α-Phellandrene100299711620.765tr0.1tr0.1-RI, MS
7δ-3-Carene1010100511460.765tr0.1tr0.1-RI, MS
8α-Terpinene1013100911780.765tr0.10.10.2trRI, MS, 13C-NMR
9p-Cymene1015101212680.6980.40.3tr0.1-RI, MS, 13C-NMR
10Limonene1025102111990.7650.12.41.10.2trRI, MS, 13C-NMR
11(Z)-β-Ocimene1029102512300.7650.87.83.436.610.2RI, MS, 13C-NMR
12(E)-β-Ocimene1041103612470.7650.54.84.530.53.4RI, MS, 13C-NMR
13γ-Terpinene1051104812420.7650.20.30.20.50.1RI, MS, 13C-NMR
14Terpinolene1082107812790.765tr0.1tr0.1-RI, MS
15Linalool1086108315430.8690.10.2tr0.1trRI, MS, 13C-NMR
16allo-Ocimene1113111713700.7650.10.20.11.30.4RI, MS, 13C-NMR
17Terpinen-4-ol1164116115970.8690.10.2-tr0.1RI, MS, 13C-NMR
18Neral1215121216790.887-0.1-tr0.1RI, MS
19Geraniol1235123318430.8690.2-0.1trtrRI, MS, 13C-NMR
20Geranial1244124417400.887trtr0.1-0.1RI, MS
21Thymol1267126721780.8081.7-tr0.2-RI, MS, 13C-NMR
22Carvacrol1278127722190.808-tr--1.0RI, MS, 13C-NMR
23Eugenol1331132821700.808----0.4RI, MS, 13C-NMR
24Bicycloelemene1338133114850.751-0.2--0.1RI, MS, 13C-NMR
25δ-Elemene1340133414640.751-3.9tr0.31.9RI, MS, 13C-NMR
26α-Cubebene1355134714520.751-0.10.10.2-RI, MS, 13C-NMR
27α-Ylangene1376136814750.751-0.1tr0.10.1RI, MS
28α-Copaene1379137414850.751-0.20.90.80.1RI, MS, 13C-NMR
29β-Cubebene1390138415390.7510.7--0.30.1RI, MS, 13C-NMR
30β-Elemene1389138515830.751tr3.11.61.31.2RI, MS, 13C-NMR
31α-Funebrene1385138615180.7510.6--tr-RI, MS, 13C-NMR
32Sesquithujene1399140015490.7510.2tr-tr-RI, MS, 13C-NMR
33Cyperene1402140415240.751-0.3--trRI, MS, 13C-NMR
34cis-α-Bergamotene1411140915610.7512.3tr---RI, MS, 13C-NMR
35(E)-β-Caryophyllene *1421141615890.7511.76.85.02.212.4RI, MS, 13C-NMR
36α-Santalene *1422141615650.7518.5tr0.1--RI, MS, 13C-NMR
37β-Copaene *1430142615740.7510.3--0.20.1RI, MS, 13C-NMR
38γ-Elemene *#1429142616300.751-6.9trtr0.3RI, MS, 13C-NMR
39trans-α-Bergamotene1434143115780.75111.7--trtrRI, MS, 13C-NMR
40Sesquisabinene A1435143416360.7511.3---trRI, MS, 13C-NMR
41β-Sesquifenchene1437143916110.7510.5-tr--RI, MS, 13C-NMR
42epi-β-Santalene1446144116260.7510.50.1tr--RI, MS, 13C-NMR
43(E)-β-Farnesene1446144616600.7512.10.10.1tr-RI, MS, 13C-NMR
44α-Humulene1455144816620.7510.81.21.30.51.9RI, MS, 13C-NMR
45β-Santalene1460145316430.7510.2-tr--RI, MS, 13C-NMR
46(5αH,10βMe)-6,12-Oxido-
elema-1,3,6,11(12)-tetraene #
1455 c145518370.853-10.30.1-1.8RI, MS, 13C-NMR
47Ishwarane1468146016440.7510.2----RI, MS, 13C-NMR
48β-Acoradiene1465146116690.7510.2--tr-RI, MS, 13C-NMR
496,12-Oxido-germacra-
1(10),4,6,11(12)-tetraene #
1463 c146318450.853-1.0--0.2RI, MS, 13C-NMR
50α-Curcumene1473146917660.7071.10.2trtr-RI, MS, 13C-NMR
51γ-Muurolene1474147116830.7510.82.50.30.30.2RI, MS, 13C-NMR
52Germacrene D1479147417000.7510.27.523.613.816.3RI, MS, 13C-NMR
53trans-β-Bergamotene1480147816760.75110.90.5tr--RI, MS, 13C-NMR
54β-Selinene1486148417100.7510.10.10.1tr1.8RI, MS, 13C-NMR
55α-Zingiberene1489148517120.7510.4--0.1-RI, MS, 13C-NMR
56α-Selinene1494149017230.7510.1---1.4RI, MS, 13C-NMR
57Bicyclogermacrene *1494149117210.7510.10.11.80.7-RI, MS, 13C-NMR
58α-Muurolene *1496149117200.751tr--0.20.1RI, MS, 13C-NMR
59(Z)-α-Bisabolene1494149217240.7510.10.1---RI, MS
60γ-Cadinene1507149317530.751-0.10.20.10.1RI, MS, 13C-NMR
61β-Bisabolene1503150017190.7518.70.10.2tr-RI, MS, 13C-NMR
62(E,E)-α-Farnesene1498150117480.7510.70.3---RI, MS, 13C-NMR
63β-Curcumene1503150217360.7510.4----RI, MS, 13C-NMR
64(Z)-γ-Curcumene1493150617320.7510.80.2---RI, MS, 13C-NMR
65β-Sesquiphellandrene1516151217660.7510.4----RI, MS, 13C-NMR
66δ-Cadinene1520151417530.751-tr2.50.80.3RI, MS, 13C-NMR
67cis-Lanceol1525 d151720870.8190.3tr0.90.2-RI, MS, 13C-NMR
68(Z)-γ-Bisabolene1505152117210.7510.90.61.40.2-RI, MS, 13C-NMR
69trans-Sesquisabinene hydrate1530 e153019840.8192.00.3tr0.1-RI, MS, 13C-NMR
70(E)-α-Bisabolene1530153117610.7510.6tr---RI, MS, 13C-NMR
71(10βH)-1β,8β-Oxido-cadin-4-ene1534 f153418530.8309.30.47.31.3-RI, MS, 13C-NMR
72β-Elemol1541153620770.8190.40.7tr1.21.7RI, MS, 13C-NMR
73(E)-Nerolidol1553154720340.8191.10.10.50.3-RI, MS, 13C-NMR
74Germacrene B #1552154918180.751-20.80.40.12.5RI, MS, 13C-NMR
75Santalenone1576156019800.84113.0tr---RI, MS, 13C-NMR
76cis-Sesquisabinene hydrate1565 e156220790.8190.8tr0.30.1-RI, MS, 13C-NMR
77Germacra-1(10),5-dien-4β-ol1572 g156420470.8190.1trtr0.1-RI, MS, 13C-NMR
78Caryophyllene oxide1578156719730.8300.30.80.1-0.1RI, MS, 13C-NMR
79Guaiol1593158121190.8192.3trtr-trRI, MS, 13C-NMR
80Germacrene D-8-one1588 h158420660.8410.50.18.70.6trRI, MS, 13C-NMR
81Humulene oxide II1602159720420.8300.1tr0.4--RI, MS, 13C-NMR
82epi-Cubenol1602160520460.8190.20.3---RI, MS, 13C-NMR
83Alismol1619160922450.830-0.60.1--RI, MS, 13C-NMR
84Eremoligenol1614161421960.8190.3---0.5RI, MS, 13C-NMR
85γ-Eudesmol1618162021720.819tr0.91.2tr0.4RI, MS, 13C-NMR
86Muurola-4,10(14)-dien-8β-ol1632 i162921860.8300.90.13.20.3-RI, MS, 13C-NMR
87β-Eudesmol1641163522250.819tr0.2--22.5RI, MS, 13C-NMR
88α-Cadinol1643163722310.8190.20.70.6tr-RI, MS, 13C-NMR
89α-Eudesmol1653163922160.819-0.1--12.4RI, MS, 13C-NMR
90Tumerone-ar1643164222520.841--0.1-0.1RI, MS
91β-Bisabolol1659165321440.8191.10.10.2tr-RI, MS, 13C-NMR
92(7αH)-Germacrene D-8α-ol *1657 f165723550.819tr-7.80.7-RI, MS, 13C-NMR
93(7αH)-Germacrene D-8β-ol *1657 f165723550.819tr-2.60.2-RI, MS, 13C-NMR
94α-Bisabolol1673166422080.8190.7tr1.40.1-RI, MS, 13C-NMR
95epi-α-Bisabolol1667 j166722140.8190.7tr0.1--RI, MS, 13C-NMR
96Cadina-1(10),4-dien-8β-ol1676 f167622760.819tr0.37.60.3-RI, MS, 13C-NMR
97Cadina-4,10(14)-dien-8β-ol1675 i167822800.8300.10.40.8--RI, MS, 13C-NMR
98(1βH,5βH)-6,12-Oxido-guaia-
6,10(14),11(12)-trien-4α-ol
1754 c175425190.853tr1.7--0.1RI, MS, 13C-NMR
99(6αH)-Germacra-1(10),4,7(11)-
trien-6,12-γ-lactone
1856 c185628290.985-0.8---RI, MS, 13C-NMR
Hydrocarbon monoterpenes 3.219.910.070.915.7
Oxygenated monoterpenes 2.10.50.20.31.3
Hydrocarbon sesquiterpenes 58.156.139.622.240.9
Oxygenated sesquiterpenes 34.419.944.05.539.8
Other compounds ----0.4
Total 97.896.493.898.998.1
a Order of elution and percentages are given on an apolar column (BP-1), except components with an asterisk (*), where percentages are taken on a polar column (BP-20). (#) Thermolabile compound, percentage evaluated by a combination of GC-FID and 13C-NMR data [23,24]. b RIl: Retention indices reported in the Terpenoids Library Website [25] or in reference c [15]; d [26]; e [27]; f [16]; g [28]; h [14]; i [29]; j [30]. RIa, RIp: retention indices measured on apolar and polar capillary column, respectively. RRF: relative response factors calculated using methyl octanoate as internal standard. The relative proportions of constituent are expressed in g/100 g. (-): not detected; tr: traces level (<0.05%). S2: sample 2; the same for S14, S24, S44 and S47. 13C-NMR: compounds identified by NMR in the essential oil samples and obvious in at least one fraction of chromatography; 13C-NMR (italic): compounds identified by NMR in fractions of chromatography.
Table 2. Chemical variability of the leaf essential oil from Isolona dewevrei (main constituents).
Table 2. Chemical variability of the leaf essential oil from Isolona dewevrei (main constituents).
Component [a]RIa [b]RIp [b]Group IGroup IIGroup III
Subgroup I−ASubgroup I−BSubgroup II−ASubgroup II−BSubgroup III−ASubgroup III−B
M% ± SDMinMaxM% ± SDMinMaxM% ± SDMinMaxM% ± SDMinMaxM% ± SDMinMaxM% ± SDMinMax
Limonene102111990.1 ± 0.1tr0.20.8 ± 0.60.11.84.4 ± 3.41.813.01.0 ± 1.00.12.12.5 ± 1.81.16.30.1 ± 0.2tr0.4
(Z)-β-Ocimene1025123018.0 ± 12.510.236.60.7 ± 0.40.21.15.9 ± 2.70.19.213.2 ± 5.27.822.74.5 ± 1.63.08.812.1 ± 2.09.414.0
(E)-β-Ocimene1036124711.4 ± 12.83.430.50.6 ± 0.40.21.23.7 ± 1.4-5.14.6 ± 1.61.86.23.8 ± 1.32.26.47.0 ± 1.64.99.1
(E)-β-Caryophyllene *141615898.0 ± 2.52.212.43.0 ± 0.91.73.89.0 ± 1.86.812.17.5 ± 2.53.410.78.2 ± 2.85.011.65.2 ± 2.12.68.1
α-Santalene *14161565---5.2 ± 1.84.18.5tr-0.1tr-0.10.1 ± 0.1-0.2tr-0.1
γ-Elemene #142616300.3 ± 0.2-0.50.8 ± 0.6tr1.36.3 ± 1.34.07.94.2 ± 2.41.47.50.4 ± 0.4tr1.10.4 ± 0.10.10.5
trans-α-Bergamotene14311578---7.8 ± 2.56.011.7tr-trtr-0.1tr-trtr-tr
(5αH,10βMe)-6,12-Oxido-elema-1,3,6,11(12)-tetraene #145518371.3 ± 0.9-1.80.6 ± 0.6-1.47.8 ± 3.13.213.76.3 ± 4.4tr10.60.9 ± 0.8-2.21.1 ± 0.70.42.2
Germacrene D1474170012.6 ± 3.09.916.31.7 ± 1.10.22.85.7 ± 2.00.98.113.6 ± 5.24.017.824.1 ± 3.420.529.227.6 ± 4.123.134.0
trans-β-Bergamotene14781676---7.8 ± 2.06.110.90.6 ± 0.20.41.10.2 ± 0.2-0.50.1 ± 0.0tr0.1tr-0.2
β-bisabolene15001719---5.0 ± 2.62.68.70.1 ± 0.10.10.2tr-0.10.3 ± 0.10.20.40.1 ± 0.2-0.5
(10βH)-1β,8β-Oxido-cadina-4-ene153418530.3 ± 0.7-1.310.9 ± 2.18.713.70.4 ± 0.20.20.91.3 ± 1.2-2.76.4 ± 0.55.57.34.0 ± 2.8-6.2
Germacrene B #154918182.6 ± 1.80.14.11.7 ± 1.1-2.818.5 ± 4.112.224.517.2 ± 4.113.224.82.0 ± 1.10.44.02.3 ± 1.60.64.5
Santalenone15601980---9.0 ± 2.76.913.0tr-0.1tr-0.1------
Germacrene D-8-one158420660.2 ± 0.3tr0.60.7 ± 0.30.31.10.1 ± 0.1-0.30.6 ± 0.6tr1.26.1 ± 2.23.28.72.3 ± 1.6tr3.6
β-Eudesmol1635222513.4 ± 9.7-22.50.3 ± 0.3-0.80.0 ± 0.1-0.2tr-tr---2.4 ± 3.7-9.2
α-Eudesmol163922167.6 ± 5.5-12.40.4 ± 0.4-0.9tr-0.1tr-tr---1.5 ± 2.2-5.6
(7βH)-Germacrene D-8α-ol #165723550.2 ± 0.4-0.70.2 ± 0.2tr0.50.1 ± 0.1-0.30.9 ± 0.6tr1.54.7 ± 2.32.07.82.0 ± 1.5-3.6
Cadina-1(10),4-dien-8β-ol167622760.1 ± 0.2-0.30.9 ± 0.8tr1.90.3 ± 0.20.20.71.4 ± 1.20.13.25.7 ± 1.24.17.63.5 ± 2.6-6.2
Essential oil extraction Yields (%) 0.3 ± 0.20.10.50.3 ± 0.10.20.40.1 ± 0.00.10.20.3 ± 0.10.10.40.2 ± 0.10.20.30.3 ± 0.10.10.4
[a] Order of elution and percentages on apolar column (BP-1), except components with an asterisk (*), percentages on polar column (BP-20); (#) percentages calculated by combination of GC(FID) and 13C NMR; [b] RIa, RIp: Retention indices measured on apolar and polar capillary column, respectively; M% ± SD: mean percentage and standard deviation; (-): not detected; tr: traces level (<0.05%).
Table 3. IC50 values and in vitro anti-inflammatory activity of Isolona dewevrei leaf essential oil.
Table 3. IC50 values and in vitro anti-inflammatory activity of Isolona dewevrei leaf essential oil.
Percentage Inhibition of LOXIC50 (mg/mL)
Concentration #Inhibition (%)Concentration #Inhibition (%)Essential oil0.020 ± 0.005
0.00510.3 ± 0.80.01547.9 ± 10.4* NDGA0.013 ± 0.003
0.01012.7 ± 0.70.02051.5 ± 13.8
Values are means of triplicates ± standard deviation; * NDGA: NorDihydroGuaiaretic Acid; # mg/mL.
Table 4. Weights of fractions from column chromatography.
Table 4. Weights of fractions from column chromatography.
SamplesFractions Weights (g)Total (g)
F1
P: 100%
F2
P: 100%
F3
P/DE: 98/2%
F4
P/DE: 95/5%
F5
P/DE: 90/10%
F6
P/DE: 80/20%
F7
DE: 100%
S2 (4.115 g)1.3011.1870.1970.4020.4890.2120.3074.095
S14 (4.820 g)2.4701.1090.1440.2850.4130.1410.1904.752
S24 (3.702 g)1.2210.5060.2010.4780.6150.2460.3523.619
S44 (4.226 g)2.5431.3710.0310.0890.0820.0290.0324.177
S47 (3.910 g)1.2560.9400.1840.4710.5210.1790.3123.863
P: n-pentane; DE: Diethyl ether.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kambiré, D.A.; Boti, J.B.; Kablan, A.C.L.; Ballo, D.; Paoli, M.; Brunini, V.; Tomi, F. Chemical Variability and In Vitro Anti-Inflammatory Activity of Leaf Essential Oil from Ivorian Isolona dewevrei (De Wild. & T. Durand) Engl. & Diels. Molecules 2021, 26, 6228. https://doi.org/10.3390/molecules26206228

AMA Style

Kambiré DA, Boti JB, Kablan ACL, Ballo D, Paoli M, Brunini V, Tomi F. Chemical Variability and In Vitro Anti-Inflammatory Activity of Leaf Essential Oil from Ivorian Isolona dewevrei (De Wild. & T. Durand) Engl. & Diels. Molecules. 2021; 26(20):6228. https://doi.org/10.3390/molecules26206228

Chicago/Turabian Style

Kambiré, Didjour Albert, Jean Brice Boti, Ahmont Claude Landry Kablan, Daouda Ballo, Mathieu Paoli, Virginie Brunini, and Félix Tomi. 2021. "Chemical Variability and In Vitro Anti-Inflammatory Activity of Leaf Essential Oil from Ivorian Isolona dewevrei (De Wild. & T. Durand) Engl. & Diels" Molecules 26, no. 20: 6228. https://doi.org/10.3390/molecules26206228

APA Style

Kambiré, D. A., Boti, J. B., Kablan, A. C. L., Ballo, D., Paoli, M., Brunini, V., & Tomi, F. (2021). Chemical Variability and In Vitro Anti-Inflammatory Activity of Leaf Essential Oil from Ivorian Isolona dewevrei (De Wild. & T. Durand) Engl. & Diels. Molecules, 26(20), 6228. https://doi.org/10.3390/molecules26206228

Article Metrics

Back to TopTop